stock
Alnylam Pharmaceuticals Inc
NASDAQ | ALNY
412.63
USD
+$0.00
(+0.00%
)At Close (As of Dec 11, 2025)
$53.43B
Market Cap
1444.5
P/E Ratio
0.28
EPS
$495.55
52 Week High
$205.87
52 Week Low
HEALTHCARE
Sector
ALNY Chart
Recent Chart
Price Action
ALNY Technicals
ALNY Earnings
Earnings Performance
ALNY Financials
yearly Cash Flow (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Operating Cashflow | -$8.3M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $57M |
| Capital Expenditures | $34M |
| Change In Receivables | - |
| Change In Inventory | $14M |
| Profit Loss | - |
| Cashflow From Investment | -$117M |
| Cashflow From Financing | $294M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | - |
| Dividend Payout Common Stock | - |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | - |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | -$278M |
ALNY News
ALNY Profile
Alnylam Pharmaceuticals Inc Profile
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Alnylam Pharmaceuticals, Inc. is a pioneering biopharmaceutical company headquartered in Cambridge, Massachusetts, specializing in the development and commercialization of transformative RNA interference (RNAi) therapeutics aimed at addressing genetic diseases. The company boasts a robust pipeline of innovative RNAi-based therapies and has made significant strides in the market, including the successful launch of its first commercial product. With a steadfast commitment to scientific excellence and the advancement of medicine, Alnylam is positioned as a leader in the biopharmaceutical sector, striving to redefine treatment paradigms for both rare and prevalent diseases.
ATPC +164.70%
$0.18
LPTX +368.57%
$2.05
NVDA -1.55%
$180.93
WOK -11.52%
$0.16
PAVS -9.21%
$0.03
VSME +11.42%
$0.09
PETS +68.36%
$2.98
RZLT -87.20%
$1.40
YGMZ -61.42%
$0.02
PLUG +4.42%
$2.36
ORCL -10.83%
$198.85
RIVN -6.11%
$16.43
ASST -7.82%
$0.92
VIVK +14.55%
$0.07
URG -8.08%
$1.25
KIND +9.48%
$2.77
NXDR
+9.48%
$2.77
AXDX -61.36%
$0.03
IVP -12.52%
$0.05
ONDS +8.34%
$9.02
IRBT -4.58%
$5.00
INTC -3.11%
$39.51
F +1.64%
$13.63
MIGI -8.95%
$6.10
TSLA -1.01%
$446.89
KVUE 0.00%
$17.32
BTTC
+24.28%
$4.12
ADAP -15.14%
$0.05
DNN +2.60%
$2.76
AAL -1.18%
$14.96
AVGO -1.59%
$406.37
HOOD -9.05%
$123.38
MARA -0.67%
$11.84
NFLX +1.48%
$94.09
TE -4.55%
$5.87
K -0.01%
$83.44
SOND -23.45%
$0.12
GOOGL -2.42%
$312.43
SOFI -0.07%
$27.07
BMNR
-5.00%
$38.38
WBD -0.13%
$29.49
BTG 0.00%
$4.68
RR +12.77%
$4.68
VALE +2.30%
$13.29
RMBL +60.50%
$3.21
LNW -3.71%
$86.22
T -0.36%
$24.30
RGTI +2.90%
$26.88
BYND -4.06%
$1.18
ADD -25.47%
$0.05
NIO +1.98%
$5.13
PLTR -0.19%
$187.54
BAC +0.88%
$54.56
SRM +53.27%
$10.30
PFE +0.07%
$25.80
HL +12.56%
$19.35
ASBP +22.50%
$0.10
PLTD +0.15%
$6.32
AAPL -0.26%
$278.03
GRAB 0.00%
$5.18
BITF 0.00%
$2.94
HPE -2.85%
$24.54
RIG -0.46%
$4.28
RKLB +10.44%
$63.53
JBLU -2.78%
$4.89
QBTS +4.40%
$27.98
AMD +0.00%
$221.43
BMNU
-10.03%
$10.22
CIFR +2.16%
$18.88
NGD +9.19%
$8.55
ACHR +2.27%
$8.56
AG +7.13%
$16.81
CDE +9.45%
$17.48
AMZN -0.64%
$230.28
MTSR -0.35%
$70.50
BBD +2.71%
$3.41
BTBT +4.23%
$2.46
SNAP -3.53%
$7.64
CRWV
-0.88%
$87.38
IREN +0.04%
$43.94
NCLH +6.80%
$20.55
ABEV +2.04%
$2.50
FI +2.38%
$68.16
GOOG -2.27%
$313.70
NOK +2.25%
$6.36
MSFT +1.02%
$483.47
HBAN +1.99%
$17.91
CCL +5.93%
$27.84
PCG -1.65%
$14.83
AFMD -34.94%
$0.18
KO -1.56%
$69.11
SMCI -2.52%
$34.02
WULF +0.44%
$15.83
LUV +2.28%
$40.74
UBER +1.52%
$85.44
SOUN -1.47%
$12.03
SMR +4.42%
$21.22
CHR -5.72%
$0.04
CLSK +1.99%
$14.82
EXK +4.20%
$9.41
ATPC +164.70%
$0.18
LPTX +368.57%
$2.05
NVDA -1.55%
$180.93
WOK -11.52%
$0.16
PAVS -9.21%
$0.03
VSME +11.42%
$0.09
PETS +68.36%
$2.98
RZLT -87.20%
$1.40
YGMZ -61.42%
$0.02
PLUG +4.42%
$2.36
ORCL -10.83%
$198.85
RIVN -6.11%
$16.43
ASST -7.82%
$0.92
VIVK +14.55%
$0.07
URG -8.08%
$1.25
KIND +9.48%
$2.77
NXDR
+9.48%
$2.77
AXDX -61.36%
$0.03
IVP -12.52%
$0.05
ONDS +8.34%
$9.02
IRBT -4.58%
$5.00
INTC -3.11%
$39.51
F +1.64%
$13.63
MIGI -8.95%
$6.10
TSLA -1.01%
$446.89
KVUE 0.00%
$17.32
BTTC
+24.28%
$4.12
ADAP -15.14%
$0.05
DNN +2.60%
$2.76
AAL -1.18%
$14.96
AVGO -1.59%
$406.37
HOOD -9.05%
$123.38
MARA -0.67%
$11.84
NFLX +1.48%
$94.09
TE -4.55%
$5.87
K -0.01%
$83.44
SOND -23.45%
$0.12
GOOGL -2.42%
$312.43
SOFI -0.07%
$27.07
BMNR
-5.00%
$38.38
WBD -0.13%
$29.49
BTG 0.00%
$4.68
RR +12.77%
$4.68
VALE +2.30%
$13.29
RMBL +60.50%
$3.21
LNW -3.71%
$86.22
T -0.36%
$24.30
RGTI +2.90%
$26.88
BYND -4.06%
$1.18
ADD -25.47%
$0.05
NIO +1.98%
$5.13
PLTR -0.19%
$187.54
BAC +0.88%
$54.56
SRM +53.27%
$10.30
PFE +0.07%
$25.80
HL +12.56%
$19.35
ASBP +22.50%
$0.10
PLTD +0.15%
$6.32
AAPL -0.26%
$278.03
GRAB 0.00%
$5.18
BITF 0.00%
$2.94
HPE -2.85%
$24.54
RIG -0.46%
$4.28
RKLB +10.44%
$63.53
JBLU -2.78%
$4.89
QBTS +4.40%
$27.98
AMD +0.00%
$221.43
BMNU
-10.03%
$10.22
CIFR +2.16%
$18.88
NGD +9.19%
$8.55
ACHR +2.27%
$8.56
AG +7.13%
$16.81
CDE +9.45%
$17.48
AMZN -0.64%
$230.28
MTSR -0.35%
$70.50
BBD +2.71%
$3.41
BTBT +4.23%
$2.46
SNAP -3.53%
$7.64
CRWV
-0.88%
$87.38
IREN +0.04%
$43.94
NCLH +6.80%
$20.55
ABEV +2.04%
$2.50
FI +2.38%
$68.16
GOOG -2.27%
$313.70
NOK +2.25%
$6.36
MSFT +1.02%
$483.47
HBAN +1.99%
$17.91
CCL +5.93%
$27.84
PCG -1.65%
$14.83
AFMD -34.94%
$0.18
KO -1.56%
$69.11
SMCI -2.52%
$34.02
WULF +0.44%
$15.83
LUV +2.28%
$40.74
UBER +1.52%
$85.44
SOUN -1.47%
$12.03
SMR +4.42%
$21.22
CHR -5.72%
$0.04
CLSK +1.99%
$14.82
EXK +4.20%
$9.41